Apogee Therapeutics, Inc. Accounts Payable
Apogee Therapeutics, Inc. (APGE) had Accounts Payable of $3.08 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $3.08M.
- 2026-03-31: Accounts Payable, Current $1.24M.
- 2025-12-31: Accounts Payable, Current $1.22M.
- 2025-09-30: Accounts Payable, Current $376.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.08M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.24M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.22M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $376.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $5.68M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $2.44M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.07M 10-K · filed 2026-03-02 |
| 2024-09-30 | $2.22M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.53M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $4.30M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.14M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.21M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $11.15M 10-Q · filed 2023-08-28 |
| 2022-12-31 | $418.00K 10-K · filed 2024-03-05 |